A study published in BioMed Central (BMC) Dermatology has suggested that the outcome from clinical treatment with adjuvant therapies, such as facial cleansing, topical treatments and moisturising, can greatly affect the improvement of mild-to-moderate acne vulgaris.
The study, which evaluated 643 participants in an observational, non-interventional prospective study, assessed the effects of both clinical and adjuvant methods with 566 patients completing three study visits over a three-month study period.
An ECOB, which is a validated questionnaire used by researchers was used to assess clinical adherence, as well as a 0-5 point scale to monitor treatment adherence and acne severity post treatment.
Overall, clinical improvement was observed throughout follow-up visits with an increased amount of patients reporting reductions of more than 50% on the total number of lesions (two months: 25.2%; three months: 57.6%) and reductions of severity scores (2.5, 2.0 and 1.3 at one, two and three months after treatment).
Adherence to treatment was associated with a significant reduction on severity grading, a lower number of lesions and a higher proportion of patients with more than a 50% improvement.